Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Ahmad et al., 2020
Heliyon 10 (16), e36131
Initially approved to treat diabetes, glucagon-like peptide-1 (GLP-1) drugs are being heralded to address obesity and, more recently, obstructive sleep apnea (OSA)
The basal insulin dose was decreased by 20% at randomization, and Victoza was initiated at 0.6 mg/day and was titrated to 1.2 mg and 1.8 mg over the course of 2-3 weeks based on tolerability and an average fasting plasma glucose goal of 110 mg/dL
US$ 26.81
US$ 29.03
US$ 25.88
US$ 24.30
US$ 26.81
US$ 24.01
US$ 23.17
US$ 21.43
US$ 26.74
US$ 21.05
